智通财经APP讯，梅斯健康(02415)发布公告，预期集团于截至2025年6月30日止六个月录得股东应占溢利不少于人民币1000万元，而截至2024年6月30日止六个月则录得股东应占溢利人民币20万元。集团预期溢利增加主要归因于以下各项：(i)制药行业复苏，以及国内制药企业对循证驱动型营销模式的加速转型，带动精准全渠道营销解决方案需求增长;(ii)人工智能应用赋能提升集团各业务分部生产效率;及(iii)积极实施环境、社会及管治原则，从而更有效控制运营成本。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.